Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10.6M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
4.17M
-
Shares change
-
+3.71M
-
Total reported value, excl. options
-
$26.3M
-
Value change
-
+$23.4M
-
Number of buys
-
12
-
Number of sells
-
-3
-
Price
-
$6.30
Significant Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q1 2020
18 filings reported holding NEPH - NEPHROS INC - Common Stock - $0.001 par value as of Q1 2020.
NEPHROS INC - Common Stock - $0.001 par value (NEPH) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.17M shares
of 10.6M outstanding shares and own 39.23% of the company stock.
Largest 10 shareholders include WEXFORD CAPITAL LP (3.4M shares), Parkman Healthcare Partners LLC (251K shares), Cowen Prime Services LLC (155K shares), INGALLS & SNYDER LLC (133K shares), VANGUARD GROUP INC (56.7K shares), HighTower Advisors, LLC (43.2K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (39.9K shares), BLAIR WILLIAM & CO/IL (34.2K shares), MILLENNIUM MANAGEMENT LLC (20K shares), and National Asset Management, Inc. (14.4K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.